Bionano Genomics, Inc. (NASDAQ:BNGO) Q3 2024 Earnings Call Transcript November 13, 2024 4:30 PM ET
Company Participants
David Holmes – IR
Erik Holmlin – CEO and Principal Financial Officer
Conference Call Participants
Sung Ji Nam – Scotiabank
Destiny Hance – Ladenburg Thalmann
Mark Massaro – BTIG
Operator
Good day, and welcome to the Bionano Third Quarter 2024 Earnings Conference Call. Today’s conference is being recorded. At this time, I would like to turn the conference over to David Holmes from Investor Relations. Please go ahead.
David Holmes
Thank you, operator, and good afternoon, everyone. Welcome to the Bionano third quarter 2024 financial results conference call. Leading the call today is Dr. Erik Holmlin, CEO and Principal Financial Officer of Bionano. And he is joined by Mark Adamchak, Bionano’s Vice President of Accounting and Principal Accounting Officer. After market today, Bionano issued a press release announcing its financial results for the third quarter 2024. A copy of the release can be found on the Investor Relations page of the company’s website. Bionano expects to file its Form 10-Q no later than 530 p.m. Eastern time tomorrow, November 14th.
Certain statements made during this conference call may be forward-looking statements, including statements about Bionano’s revenue outlook, profitability, cash runway, cost savings initiatives, and commercialization and product plans. Such statements are based on current expectations and there can be no assurances that the results contemplated in these statements will be realized. Actual results may differ materially from such statements due to a number of risks and factors, some of which are identified in Bionano’s press release and Bionano’s reports filed with the SEC. These forward-looking statements are based on information available to Bionano today, November 13, 2024, and the company assumes no obligation to update statements as circumstances change.
In addition, to supplement Bionano’s
Read the full article here
